Ligand validation:7AOL

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7AOL_IMD_A_402	23%	74%	0.129	0.752	0.41	0.61	-	-	0	0	100%	0.97
7B83_IMD_A_402	60%	59%	0.153	0.94	0.78	0.78	-	-	0	0	100%	1
7AX6_IMD_A_404	57%	80%	0.112	0.887	0.41	0.43	-	-	0	0	100%	1
7AY7_IMD_A_405	48%	73%	0.148	0.892	0.4	0.63	-	-	0	0	100%	1
7ABU_IMD_A_402	46%	74%	0.139	0.875	0.43	0.58	-	-	0	0	100%	1
7NEV_IMD_A_404	38%	74%	0.13	0.831	0.44	0.58	-	-	0	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.